This study successfullydeveloped and characterized Zein/Eudragitcomposite NPS (ZEU/INS NPS) for the intranasal delivery of insulin,demonstrating their potential as an alternative to conventional parenteraladministration for the treatment of T1DM. Here, INS is linked to type 1 diabetes mellitus.